Navigation
Navigation
User login
Back to top

The Haematological Malignancy Research Network provides information about leukaemias, lymphomas, myelomas, and related blood disorders. Our statistics are based on data from the UK, and use the World Health Organization’s Classification for Oncology (ICD-O-3) which currently recognises over 100 different haematological malignancy subtypes.

If you are a participant in our research, you can find more information on our patient hub, YHHN.org.

What's new?

New research

We wanted to explore how treatment decision making (TDM) was happening with a group of patients with chronic blood cancers. These cancers are complex, some requiring intermittent treatment over many years. Little is known about the views of these patients regarding the decision-making processes for their treatment.

Read all about it here.

Read the research paper:

Treatment decision making: Exploring the perspectives of patients with chronic blood cancers

New publication

We are delighted to announce a comparison cohort for the HMRN. This cohort allows us to compare the health of patients with blood cancer to similar people in the general population who are cancer-free. These comparisons are helping us find out more about how blood cancers (leukaemias, lymphomas, multiple myeloma) relate to other conditions and illnesses.  

Read all about it here.

Read the research paper: Cohort Profile Update: HMRNs UK population-based cohorts

Network members

NHS haematology staff in the HMRN clinical network can access the Members' section here (active HMRN account required)

Visit members' section